Heat Stroke STUDY 2012
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Japan Accreditation Council for Medical Education
Japan Accreditation Council for Medical Education We devote ourselves to the advancement of medicine and health care through quality assurance of medical education based on global standards To make the quality of medical education in Japan higher Japan Accreditation Council for Medical Education (JACME) The Japan Accreditation Council for Medical Education (JACME) was constituted to strengthen and advance medical education, and to contribute to public health, health care, welfare, and global health, by assuring the quality of medical education in Japan from an international standpoint. To accomplish this mission, the organization is designed to carry out a dispassionate and proper evaluation of medical education programs in Japan, on the basis of the schools’ founding principles and the World Federation for Medical Education (WFME) Global Standards for Quality Improvement of Medical Education. JACME supports the following initiatives: (1) The establishment and review of medical (5) The publication of official journals and education evaluation criteria. academic books relating to medical education programs. (2) The evaluation of medical education programs. (6) Collaborations with domestic and foreign organizations; the collection of information (3) Education initiatives designed to enhance and about the evaluation of medical education improve medical education programs. in foreign countries. (4) Studies and research to enhance and improve (7) Other activities necessary to achieve the medical education programs. objectives of JACME. President’s Address Japan Accreditation Council for Medical Education President Fumimaro Takaku, M.D., Ph.D. At the third meeting of the preparatory committee for establishment of Japan Accreditation Council for Medical Education (JACME) held in July 2015, I was unexpectedly appointed as President of JACME. -
Algorithm of the JJ Risk Engine
SUPPLEMENTARY DATA Algorithm of the JJ risk engine. The JJ risk engine calculates t-year probabilities of fatal and non-fatal coronary heart disease, fatal and non-fatal stroke, non-cardiovascular mortality, overt nephropathy defined by persistent proteinuria and progression of retinopathy by inputting a covariate vector X and a time point for prediction t (i.e. the formula calculates 5-year probability if t=5) into the formula shown below. 2 Specifically, define X={sex (man=0, woman=1), age, HbA1C, years after diagnosis, BMI<18.5 kg/m (yes=1, no=0), BMI≥25 kg/m2 (yes=1, no=0), systolic blood pressure, non-high-density lipoprotein cholesterol, log-transformed urine albumin-to-creatinine ratio, atrial fibrillation (yes=1, no=0), current smoker (yes=1, no=0), leisure time physical activity (≥3.8METs-h/wk=1, otherwise=0) }. Let βjk be a vector of log hazard ratios for transition from state j to k; the state indexed by j=1…7 represent the initial state, presence of Stage 1 or 4 retinopathy, fatal and non-fatal coronary heart disease, fatal and non-fatal stroke, non-cardiovascular mortality, overt nephropathy defined by persistent proteinuria and progression of retinopathy, respectively. The states j=3…7 were assumed to be absorbing. The estimated hazard ratios for the JJ risk engine, exp(βjk), are provided in Table 1. Let λ0jk(t) be a baseline transition intensity for transition from state j to k. Then, the cause-specific transition intensity for a patient with covariate Xi is written as λijk(t)=λ0jk(t)exp(Xiβjk). -
Initial Blood Ammonia Level Is a Useful Prognostication Tool in Out-Of-Hospital Cardiac Arrest ― Multicenter Prospective Study (SOS-KANTO 2012 Study) ―
Advance Publication by-J-STAGE Circ J Supplementary File doi: 10.1253/circj.CJ-17-0335 Initial Blood Ammonia Level Is a Useful Prognostication Tool in Out-of-Hospital Cardiac Arrest ― Multicenter Prospective Study (SOS-KANTO 2012 Study) ― SOS-KANTO 2012 Study Group ——— Supplementary File 1 ——— Appendix S1. SOS-KANTO 2012 Investigators (Naoto Morimura, MD); National Hospital Organization Yokohama SOS-KANTO 2012 Study Group Medical Center (Ryosuke Furuya, MD); National Disaster Medical Koichiro Shinozaki (Feinstein Institute for Medical Research, Center (Yuichi Koido, MD); Yamanashi Prefectural Central Hospital Manhasset, NY, USA), Masaru Suzuki (Keio University, Tokyo, (Fumiaki Iwase, MD); Surugadai Nihon University Hospital (Ken Japan), Shigeto Oda (Chiba University, Chiba, Japan), Lance B. Nagao, MD); Yokohama Rosai Hospital (Shigeru Kanesaka, MD); Becker (Feinstein Institute for Medical Research, Manhasset, NY, Showa General Hospital (Yasusei Okada, MD); Nippon Medical USA), Takashi Tagami (Nippon Medical School Tama Nagayama School Tamanagayama Hospital (Kyoko Unemoto, MD); Tokyo Hospital, Tokyo, Japan), Atsushi Sakurai (Nihon University, Tokyo, Women’s Medical University Yachiyo Medical Center (Tomohito Japan), Yoshio Tahara (National Cerebral and Cardiovascular Center, Sadahiro, MD); Awa Regional Medical Center (Masayuki Iyanaga, Osaka, Japan), Ken Nagao (Nihon University Surugadai Hospital, MD); Todachuo General Hospital (Asaki Muraoka, MD); Japanese Tokyo, Japan), Naohiro Yonemoto (National Center of Neurology Red Cross Medical -
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009) Toshio OGIHARA, Kenjiro KIKUCHI, Hiroaki MATSUOKA, Toshiro FUJITA, Jitsuo HIGAKI, Masatsugu HORIUCHI, Yutaka IMAI, Tsutomu IMAIZUMI, Sadayoshi ITO, Hiroshi IWAO, Kazuomi KARIO, Yuhei KAWANO, Shokei KIM-MITSUYAMA, Genjiro KIMURA, Hiroaki MATSUBARA, Hideo MATSUURA, Mitsuhide NARUSE, Ikuo SAITO, Kazuyuki SHIMADA, Kazuaki SHIMAMOTO, Hiromichi SUZUKI, Shuichi TAKISHITA, Norio TANAHASHI, Takuya TSUCHIHASHI, Makoto UCHIYAMA, Shinichiro UEDA, Hirotsugu UESHIMA, Satoshi UMEMURA, Toshihiko ISHIMITSU, Hiromi RAKUGI, on behalf of The Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension Citation Information We recommend that any citations to information in the Guidelines are presented in the following format: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res 2009; 32:3–107. The full list of authors is as stated above. Hypertension Research (2009) 32, 4–5 & 2009 The Japanese Society of Hypertension All rights reserved 0916-9636/09 $32.00 www.nature.com/hr The Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension CHAIRPERSON VICE-CHAIRPERSON Toshio OGIHARA (Osaka University) Kenjiro KIKUCHI (Asahikawa Medical College) WRITING MEMBERS Toshiro FUJITA (University of Tokyo) Hideo MATSUURA (Saiseikai Kure Hospital) Jitsuo HIGAKI (Ehime University) Mitsuhide NARUSE (NHO Kyoto Medical Center) Masatsugu HORIUCHI (Ehime University)